201
Views
20
CrossRef citations to date
0
Altmetric
Review

Computational Toxicology Methods in Public Health Practice

, , , , , , , & show all
Pages 119-135 | Received 29 Oct 2007, Accepted 29 Nov 2007, Published online: 09 Oct 2008

REFERENCES

  • Agency for Toxic Substances and Disease Registry (ATSDR). Guidance Manual for the Assessment of Joint Toxic Action of Chemical Mixtures, May 2004. U.S. DHHS PHS ATSDR, Atlanta, GA 2004a, http://www.atsdr.cdc.gov/interactionprofiles/ipga.html. Accessed October 26, 2007.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Interaction Profile for Benzene, Toluene, Ethylbenzene, and Xylenes. U.S. DHHS PHS ATSDR, Atlanta, GA 2004b, 2004b http://www. atsdr.cdc.gov/interactionprofiles/ip05.html Accessed October 26, 2007.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for 1,1,2,2-Tetrachloroethane. U.S. DHHS PHS ATSDR, Atlanta, GA 2006a, http://www.atsdr.cdc.gov/toxprofiles/tp93.html. Accessed October 26, 2007.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Interaction Profile for Atrazine, Deethylatrazine, Diazinon, Nitrate and Simazine. U.S. DHHS PHS ATSDR, Atlanta, GA 2006b, 2006b http://www.atsdr.cdc.gov/interactionprofiles/ip10.html. Accessed October 26, 2007
  • Agency for Toxic Substances and Disease Registry (ATSDR). Minimal Risk Levels. U.S. DHHS PHS ATSDR, Atlanta, GA 2007a, http://www.atsdr.cdc.gov/mrls/index.html. Accessed October 26, 2007
  • Agency for Toxic Substances and Disease Registry (ATSDR). Hazardous Substance Release and Health Effects Database (HazDat). U.S. DHHS PHS ATSDR, Atlanta, GA 2007b, http://www.atsdr.cdc.gov/hazdat.html. Accessed October 26, 2007.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Boron. U.S. DHHS PHS ATSDR, Atlanta, GA 2007c, http://www.atsdr.cdc.gov/toxprofiles/tp26.html. Accessed October 26, 2007
  • Agency for Toxic Substances and Disease Registry (ATSDR). Interaction Profiles. U.S. DHHS PHS ATSDR, Atlanta, GA 2007d, http://www.atsdr.cdc.gov/interactionprofiles. Accessed October 26, 2007
  • Agency for Toxic Substances and Disease Registry (ATSDR). Interaction Profile for Chloroform, 1,1-Dichloroethylene, Trichloroethylene, and Vinyl Chloride. U.S. DHHS PHS ATSDR, Atlanta, GA 2007e, http://www.atsdr.cdc.gov/interactionprofiles/ip13.html. Accessed October 26, 2007
  • Akaike H. A new look at the statistical model identification. IEEE T. Automatic Con. 1974; 19: 716–723
  • Anand S. S., Mumtaz M. M., Mehendale H. M. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats. Arch. Toxicol. 2005; 79: 671–682
  • Andersen M. E., Clewell H. J., Gargas M. L, Macnaughton M. G., Reitz R. H., Nolan R. J., McKenna M. J. Physiologically based pharmacokinetic modeling with dichoromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharm. 1991; 108: 14–27
  • Andersen M. E., Clewell H. J., Gargas M. L, Smith F. A., Reitz R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharm. 1987a; 87: 185–205
  • Andersen M. E., Gargas M. L, Clewell H. J., Severyn K. M. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharm 1987b; 89: 149–157
  • Barton H. A., Creech J. R., Godin C. S., Randall G. M., Seckel C. S. Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene in rat. Toxicol. Appl. Pharm. 1995; 130: 237–247
  • Basak S. C., Mills D, El-Masri H. A., Mumtaz M., Hawkins D. M. Predicting blood:air partition coefficients using theoretical molecular descriptors. Environ. Toxicol. Pharm. 2004; 16: 45–55
  • Béliveau M., Tardif R., Krishnan K. Quantitative structure–property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol. Appl. Pharm. 2003; 189: 221–232
  • Benfenati E., Gini G. Computational predictive programs (expert systems) in toxicology. Toxicology 1997; 119: 213–225
  • Benigni R., Richard A. M. QSARs of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals. Mutat. Res. 1996; 371: 29–46
  • Benigni R., Richard A. M. Quantitative structure-based modeling applied to the characterization and prediction of chemical toxicity. Methods 1998; 14: 264–276
  • Chemical Abstracts Service. Registry Number and Substance Counts. American Chemical Society, Columbus, OH 2007, http://www.cas.org/cgi-bin/cas/regreport.pl. Accessed October 26, 2007.
  • Chou C.-H. S. J., Holler J. S., De Rosa C. T. Minimal risk levels for hazardous substances. J. Clean Technol. Environ. Toxicol. Occup. Medicine 1998; 7: 1–24
  • Cova D., Nebuloni C., Arnoldi A., Bassoli A., Trevisan M., DelRe A. A. M. N-nitrosation of triazines in human gastric juice. J. Agric. Food Chem. 1996; 44: 2852–2855
  • Davidson P. W., Myers G. J., Cox C., Shamlaye C. F., Marsh D. O., Tanner M. A., Berlin M., Sloane-Reeves J., Cernichiari E., Choisy O., Choi A., Clarkson T. W. Longitudinal neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from maternal fish ingestion: Outcome at 19 and 29 months. Neurotoxicology 1995; 16: 677–688
  • Demchuk E., Yucesoy B., Johnson V. J., Weston A., Germolec D., De Rosa C. T., Luster M. I. A statistical model to assess genetic susceptibility as a risk factor in multifactorial diseases: Lessons from occupational asthma. Environ. Health Persp. 2007; 115: 231–234
  • De Rosa C. T. Charge to workshop. Toxicol. Lett. 1995; 79: 7–8
  • De Rosa C. T., El-Masri H. E., Pohl H., Cibulas W., Mumtaz M. M. Implications of chemical mixtures for public health practice. J. Toxicol. Environ. Health 2004; 7: 339–350
  • Dourson M., Maier A., Meek B., Renwick A., Ohanian E., Poirier K. Boron tolerable intake re-evaluation of toxicokinetics for data derived uncertainty factors. Biol. Trace. Elem. Res. 1998; 66: 453–463
  • Dunlop W. Serial changes in renal haemodynamics during normal human pregnancy. Br. J. Obstet. Gynecol. 1981; 88: 1–9
  • Durkin P., Hertzberg R., Stiteler W., Mumtaz M. The identification and testing of interaction patterns (LOAEL). Toxicol. Lett. 1995; 79: 251–226
  • EC. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off. J. Eur. Union 2006; 49, L396
  • Eisenbrand G., Ungerer O., Preussmann R. Formation of N nitroso compounds from agricultural chemicals and nitrite. N-nitroso Compounds in the Environment, P. Bogovski, E. A. Walker, W. Davis. International Agency for Research on Cancer, Switzerland 1975; 71–74
  • El-Masri H. A., Constan A. A., Ramsdell H. S., Yang R. S. H. Physiologically based pharmacodynamic modeling of an interaction threshold between trichloroethylene and 1,1-dichloroethylene in Fischer 344 rats. Toxicol. Appl. Pharm. 1996a; 141: 124–132
  • El-Masri H. A., Mumtaz M. M., Choudhary G., Cibulas W., De Rosa C. T. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry. Int. J. Hyg. Environ. Health 2002; 205: 63–69
  • El-Masri H. A., Mumtaz M. M., Yushak M. L. Application of physiologically based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat. Environ. Toxicol. Pharmacol. 2004; 16: 57–71
  • El-Masri H. A., Tessari J. D., Yang R. S. H. Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethlene: utilization of a PBPK model. Arch. Toxicol. 1996b; 70: 527–539
  • Elsevier Information Systems GmbH. CrossFire Beilstein database exceeds ten million compounds. 2007, Press release, August 20th 2007. http://www.beilstein.com/PR_Beilstein%2010m_Final.pdf. Accessed October 26, 2007.
  • Enomoto N., Takase S., Yasuhara M., Takada A. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin. Exp. Res. 1991; 15: 141–144
  • Enslein K. The future of toxicity prediction with QSAR. In Vitro Toxicol. 1993; 6: 163–169
  • Fine D. H., Rounbehler D. P., Belcher N. M., Epstein S. S. N-nitroso compounds in air and water. Environmental N-nitroso Compounds Analysis and Formation: Proceedings of a Working Conference Held at the Polytechnical Institute, Tallinn, Estonian SSR. International Agency for Research on Cancer, WHO, Publication No. 14, Lyon, France 1976; 401–408
  • Gearhart J. M., Clewell H. J., Crump K. S., Shipp A. M., Silvers A. Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in large epidemiological study. Water Air Soil Pollut. 1995; 80: 49–58
  • Goedde H. W., Agarwal D. P., Fritze G., Meier-Tackmann D., Singh S., Beckmann G., Bhatia K., Chen L. Z., Fang B., Lisker R. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum. Genet. 1992; 88: 344–346
  • Haddad S., Béliveau M., Tardif R., Krishnan K. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicol. Sci. 2001; 63: 125–131
  • Haddad S., Charest-Tardif G., Tardif R., Krishnan K. Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures. Toxicol. Appl. Pharm. 2000; 167: 199–209
  • Haddad S., Tardif R., Charest-Tardif G., Krishnan K. Physiological modeling of the toxicokinetics interactions in a quaternary mixture of aromatic hydrocarbons. Toxicol. Appl. Pharm. 1999; 161: 249–257
  • Hansch C., Hoekman D., Leo A., Zhang L., Li P. The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol. Lett. 1995; 79: 45–53
  • Hansch C., Leo A. Exploring QSAR. Fundamentals and Applications in Chemistry and Biology. American Chemical Society, Washington, DC 1995
  • Heindel J. J., Price C. J., Field E. A., Marr M. C., Myers C. B., Morrissey R. E., Schwetz B. A. Developmental toxicity of boric acid in mice and rats. Fund. Appl. Toxicol. 1992; 18: 266–277
  • International Commission on Radiological Protection. Reference Man: Anatomical, Physiological and Metabolic Characteristics, ICRP Publication no. 23. Elsevier, New York 1975
  • International Programme on Chemical Safety. Guidance Document for the Use of Data in Development of Chemical Specific Adjustment Factors (CSAFs) for Interspecies Differences and Human Variability in Dose/Concentration Response Assessment. World Health Organization, Geneva, Switzerland 2001
  • International Programme on Chemical Safety. Chemical-Specific Adjustment Factors for Interspecies Differences and Human Variability: Guidance Document for Use of Data in Dose/Concentration-Response Assessment. Harmonization Project Document No. 2. World Health Organization, Geneva, Switzerland 2005
  • Isaacs K. K., Evans M. V., Harris T. R. Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism. J. Pharmacokinet. Pharmacodyn. 2004; 31: 215–242
  • Ishidate M. Application of chromosomal aberration tests in vitro to the primary screening for chemicals with carcinogenic and/or genetic hazards. Tests courts de cancérogénèse: Quo vadis?, S. Garattini. Centre de Recherches Clin Midy, Montpellier, France 1983; 57–79
  • Ishidate M., Sofuni T., Yoshikawa K. Chromosomal aberration tests in vitro as a primary screening tool for environmental mutagens and/or carcinogens. GANN Monogr. Cancer Res. 1981; 27: 95–108
  • Jaeger R. J., Conolly R. B., Reynolds E. S., Murphy S. D. Biochemical toxicology of unsaturated halogenated monomers. Environ. Health Perspect. 1975; 11: 121–128
  • Johnson B. L., De Rosa C. T. The toxicologic hazard of superfund hazardous waste sites. Rev. Environ. Health 1997; 12: 235–251
  • Juhl G. A., Kim E. H., Benitez J. G., Mangione S. A community exposure to 2-chloro-6-fluorophenol. Vet. Hum. Toxicol. 2003; 45: 41–42
  • Karanth S., Olivier K., Liu J., Pope C. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome. Toxicol. Appl. Pharmacol. 2001; 177: 247–255
  • Kearney P. C., Oliver J. E., Helling C. S., Isensee A. R., Kontson A. Distribution, movement, persistence, and metabolism of N nitrosoatrazine in soils and a model aquatic ecosystem. J. Agric. Food Chem. 1977; 25: 1177–1181
  • Klopman G. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Amer. Chem. Soc. 1984; 106: 7315–7320
  • Krull I. S., Mills K., Hoffman G., Fine D. H. The analysis of N-nitrosoatrazine and N-nitrosocarbaryl in whole mice. J. Anal. Toxicol. 1980; 4: 260–262
  • Krutzen F., Olofsson P., Back S. E., Nilsson-Ehle P. Glomerular filtration rate in pregnancy; a study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand. J. Clin. Lab. Invest. 1992; 52: 387–392
  • Lehman A. J., Fitzhugh O. G. 100-fold margin of safety. Assoc. Food Drug Off. U.S. Q. Bull. 1954; 18: 33–35
  • Macey R., Oster G., Zahnley T. Berkeley Madonna User's Guide, Version 5.0. University of California, Berkeley, CA 2000, http://www.berkeleymadonna.com. Accessed October 26, 2007.
  • Meisner L. F., Roloff B. D., Belluck D. A. In vitro effects of N-nitrosoatrazine on chromosome breakage. Arch. Environ. Contam. Toxicol 1993; 24: 108–112
  • Mirvish S. S., Gannett P., Babcook D. M., Williamson D., Chen S. C., Weisenburger D. D. N-nitrosoatrazine: synthesis, kinetics of formation, and NMR spectra and other properties. J. Agric. Food Chem. 1991; 39: 1205–1210
  • Mizoi Y., Yamamoto K., Ueno Y., Fukunaga T., Harada S. Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol 1994; 29: 707–710
  • Mumtaz M. M., Durkin P. R. A weight-of-evidence approach for assessing interactions in chemical mixtures. Toxicol. Ind. Health 1992; 8: 377–406
  • Mumtaz M. M., Knauf L. A., Reisman D. J., Peirano W. B., De Rosa C. T., Gombar V. K., Enslein K., Carter J. R., Blake B. W., Huque K. I. Assessment of effect levels of chemicals from quantitative structure-activity relationship (QSAR) models. I. Chronic lowest-observed-adverse-effect level (LOAEL). Toxicol. Lett. 1995; 79: 131–143
  • Mumtaz M. M., Ruiz P., De Rosa C. T. Toxicity assessment of unintentional exposure to multiple chemicals. Toxicol. Appl. Pharm. 2007; 223: 104–113
  • National Center for Environmental Health. Third National Report on Human Exposure to Environmental Chemicals. Pub. No. 05–0570 CDC, Atlanta, GA 2005
  • National Research Council. Science and Judgment in Risk Assessment. National Academies Press, Washington DC 1994a; 79
  • National Research Council. Science and Judgment in Risk Assessment. National Academies Press, Washington DC 1994b; 144
  • National Research Council. Human Biomonitoring for Environmental Chemicals. National Academies Press, Washington DC 2006
  • The National Toxicology Program. NTP Technical Report on the Toxicity Studies of 1,1,2,2-Tetrachloroethane Administered in Microcapsules in Feed to F-344/N Rats and B6C3F1 Mice. NIH Publication No. 04–4414. 2004
  • The National Toxicology Program. National Toxicology Program. Department of Health and Human Services. 2007, http://ntp.niehs.nih.gov. Accessed October 26, 2007.
  • Padilla S., Wilson V. Z., Bushnell P. J. Studies on the correlation between cholinesterase inhibition and target tissue inhibition in pesticide-treated rats. Toxicology 1994; 92: 11–25
  • Pahl M. V., Culver B. D., Strong P. L., Murray F. J., Vaziri N. D. The effect of pregnancy on renal clearance of boron in humans: a study based on normal dietary intake of boron. Toxicol. Sci. 2001; 60: 252–256
  • Parham F. M., Kohn M. C., Matthews H. B., De Rosa C. T., Portier C. J. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls: I. Tissue:blood partition coefficients. Toxicol. Appl. Pharm. 1997; 144: 340–334
  • Pimentel D., Cooperstein S., Randell H., Filiberto D., Sorrentino S., Kaye B., Nicklin C., Yagi J., Brian J., O'Hern J., Habas A., Weinstein C. Ecology of ncreasing diseases: population growth and environmental degradation. Hum. Ecol. 2007; 35: 653–668
  • Pohl H. R., Roney N., Wilbur S., Hansen H., De Rosa C. T. Six interaction profiles for simple mixtures. Chemosphere 2003; 53: 183–197
  • Price C. J., Strong P. L., Marr M. C., Myers C. B., Murray F. J. Developmental toxicity NOAEL and postnatal recovery in rats fed boric acid during gestation. Fund. Appl. Toxicol. 1996; 32: 179–193
  • Reitz R. H., Hays S. M., Gargas M. L. Addressing Priority Data Needs for Methylene Chloride with Physiologically Based Pharmacokientic Modeling. RHR Consulting Services, Midland, MI, and ChemRisk Division, McLaren/Hart, Cleveland, OH 1997, Prepared for ATSDR on behalf of the Halogenated Solvents Industry Alliance, 1–38.
  • Reitz R. H., Mendrala A. L., Park C. N., Andersen M. E., Guengerich F. P. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. Toxicol. Lett 1988; 43: 97–116
  • Russell W. M. S., Burch R. L. The Principles of Humane Experimental Technique. Methuen London 1959
  • Sanderson D. M., Earnshaw C. G. Computer prediction of possible toxic action from chemical structure; the DEREK system. Hum. Exp. Toxicol. 1991; 10: 261–273
  • Sanderson S., Emery J., Higgins J. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet. Med. 2005; 7: 97–104
  • Schou J. S., Jansen J. A., Aggerbeck B. Human pharmacokinetics and safety of boric acid. Arch. Toxicol. 1984; 7: 232–235
  • Schwetz B. A., Leong P. J., Gehring P. J. The effects of maternally inhaled trichloroethylene, perchloroethane, methyl chloroform, and methylene chloride on embryonal and fetal development in mice and rats. Toxicol. Appl. Pharm. 1975; 32: 84–96
  • Scinicariello F., De Rosa C. T. Genetic heterogeneity and its effect on susceptibility to environmental factors. Eur. J. Oncol. 2007; 12: 155–170
  • Sturgiss S. N., Wilkinson R., Davison J. M. Renal reserve during human pregnancy. Am. J. Physiol. 1996; 271: F16–F20
  • Tardif R., Charest-Tarif G., Brodeur J., Krishnan K. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol. 1997; 144: 120–134
  • U.S. Census Bureau. Census 2000 Basics. US Census Bureau, Washington, DC 2002
  • U.S. Census Bureau. 2006, http://quickfacts.census.gov/qfd. Accessed October 26, 2007.
  • U.S. Environmental Protection Agency. Guidelines for the Health Risk Assessment of Chemical Mixtures. Federal Register. 1986; vol 51 185: 34014–34025
  • U.S. Environmental Protection Agency. Supplementary Guidance for Conducting Heath Risk Assessment of Chemical Mixtures. EPA/630/R-00/002.2000a. 2002, http://cfpub.epa.gov/ncea/raf/chem_mix.cfm. Accessed October 26, 2007.
  • U.S. Environmental Protection Agency. National Priorities List Sites in the United States. U.S. EPA, Washington, DC 2007a, http://www.epa.gov/superfund/sites/npl/npl.htm. Accessed October 26, 2007.
  • U.S. Environmental Protection Agency. High Production Volume (HPV) Challenge Program. U.S. EPA, Washington, DC 2007b, http://www.epa.gov/hpv/index.htm. Accessed October 26, 2007.
  • Vanderpool R. A., Hof D., Johnson P. E. Use of inductively coupled plasma-mass spectrometry in boron-10 stable isotope experiments with plants, rats, and humans. Environ. Health Perspect. 1994; 102(Suppl 7)13–20
  • Vaziri N. D., Oveisi F., Culver B. D., Pahl M. V., Andersen M. E., Strong P. L., Murray F. J. The effect of pregnancy on renal clearance of boron in rats given boric acid orally. Toxicol. Sci. 2001; 60: 257–263
  • Welsh C. J., Moffet D., El-Masri H., Fowler D., Moore S. Evaluation of PCB exposure routes in Anniston, Alabama: assessment of fish consumption using PBPK modeling of PCB congeners in locally-caught fish. Toxicologist 2003; 72: 364
  • Williams-Johnson M. M., Henriques W., Fay R. M. Investigating ratios of health effect levels using ATSDR's HazDat database: Extrapolation methodologies in quantitative risk assessment. J. Clean. Technol. Environ. Toxicol. Occup. Med. 1996; 5: 347–360
  • Wilson J. D., Cibulas W., Choudhary G., Mumtaz M. M., De Rosa C. T. The use of decision-support tools to enhance health risk assessments at the Agency for Toxic Substances and Disease Registry. Impact of Hazardous Chemicals on Public Health, Policy and Service, C. T. De Rosa, J. S. Holler, M. A. Mehlman. International Toxicology Books, Inc., Princeton, NJ 2002; 179–200
  • Winneke G. Behavioral effects of methylene chloride and carbon monoxide as assessed by sensory and psychomotor performance. Behavioral Toxicology, C. Xintaras, B. L. Johnson, I. de Groot. U.S. Government Printing Office, Washington DC 1974; 130–144
  • Wolfe N. L., Zepp R. G., Gordon J. A., Fincher R. C. N-nitrosamine formation from atrazine. B. Environ. Contam. Toxicol. 1976; 15: 342–347
  • Woo Y.-T., Lai D., Argus M., Arcos J. Development of structure-activity relationship rules for predicting carcinogenic potential of chemicals. Toxicol. Lett. 1995; 79: 219–228

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.